Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
American Heart Journal|January 21, 2014
Amsterdam Investigator-initiateD Absorb strategy all-comers trial (AIDA trial): a clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: rationale and study designPier Woudstra, Maik J Grundeken, Robin P Kraak, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 31, 2019
Long-Term Performance of the COMBO Dual-Therapy Stent: Results from the REMEDEE RegistryLaura S Kerkmeijer, Deborah N Kalkman, Pier Woudstra, et al.
Plos One|May 3, 2014
Admission lipoprotein-associated phospholipase A2 activity is not associated with long-term clinical outcomes after ST-segment elevation myocardial infarctionPier Woudstra, Peter Damman, Wichert J Kuijt, et al.
BMJ Open|March 6, 2012
Gender difference in the prognostic value of estimated glomerular filtration rate at admission in ST-segment elevation myocardial infarction: a prospective cohort studyPeter Damman, Wouter J Kikkert, Pier Woudstra, et al.
JACC. Cardiovascular Interventions|April 11, 2020
1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score-Matched Comparison of the COMBO and Ultrathin-Strut Orsiro StentsJaya Chandrasekhar, Marlies M Kok, Deborah N Kalkman, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 20, 2018
Three-year clinical outcomes after dual-therapy COMBO stent placement: Insights from the REMEDEE registryDeborah N Kalkman, Laura S Kerkmeijer, Pier Woudstra, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 8, 2020
Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stentLaura S M Kerkmeijer, Jaya Chandrasekhar, Deborah N Kalkman, et al.
Heart (British Cardiac Society)|January 17, 2014
Clinical outcomes after final kissing balloon inflation compared with no final kissing balloon inflation in bifurcation lesions treated with a dedicated coronary bifurcation stentMaik J Grundeken, Maciej Lesiak, Solomon Asgedom, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 31, 2013
Six-month and one-year clinical outcomes after placement of a dedicated coronary bifurcation stent: a patient-level pooled analysis of eight registry studiesMaik J Grundeken, Solomon Asgedom, Peter Damman, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 9, 2020
1-Year Outcomes with COMBO Stents in Small-Vessel Coronary Disease: Subgroup Analysis From the COMBO CollaborationJaya Chandrasekhar, Doreen Zeebregts, Deborah N Kalkman, et al.
Pageof 5